Kangmei Pharmaceutical Co Ltd (600518) — Strategic Asset Allocation Index
Kangmei Pharmaceutical Co Ltd (600518) has a Strategic Asset Allocation Index of 59.4% as of June 2023. Strategic assets (PP&E of CN¥4.07 Billion plus long-term investments of CN¥-) total CN¥4.07 Billion, measured against net assets of CN¥6.86 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600518 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Kangmei Pharmaceutical Co Ltd Strategic Asset Allocation Index (2000–2021)
This chart shows how Kangmei Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2000 to 2021. As of June 2023, the index stands at 59.4%, representing strategic assets of CN¥4.07 Billion against net assets of CN¥6.86 Billion CNY. For live market cap and overall valuation, see Kangmei Pharmaceutical Co Ltd (600518) market capitalisation.
Annual Strategic Asset Allocation Index for Kangmei Pharmaceutical Co Ltd (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Kangmei Pharmaceutical Co Ltd from 2000 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Kangmei Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 46.6% | CN¥4.64 Billion | CN¥4.64 Billion | CN¥- | CN¥9.97 Billion | ▼ -8.7 pp |
| 2019 | 55.2% | CN¥11.41 Billion | CN¥11.41 Billion | CN¥- | CN¥20.65 Billion | ▲ +9.6 pp |
| 2018 | 45.7% | CN¥11.93 Billion | CN¥11.37 Billion | CN¥556.58 Million | CN¥26.12 Billion | ▲ +16.3 pp |
| 2017 | 29.3% | CN¥8.37 Billion | CN¥7.82 Billion | CN¥543.60 Million | CN¥28.52 Billion | ▲ +6.8 pp |
| 2016 | 22.6% | CN¥6.64 Billion | CN¥6.16 Billion | CN¥474.62 Million | CN¥29.38 Billion | ▼ -6.1 pp |
| 2015 | 28.7% | CN¥5.40 Billion | CN¥4.96 Billion | CN¥437.00 Million | CN¥18.84 Billion | ▲ +0.2 pp |
| 2014 | 28.5% | CN¥4.76 Billion | CN¥4.76 Billion | CN¥- | CN¥16.72 Billion | ▼ -24.5 pp |
| 2013 | 53.0% | CN¥6.38 Billion | CN¥6.38 Billion | CN¥- | CN¥12.03 Billion | ▼ -2.6 pp |
| 2012 | 55.7% | CN¥5.89 Billion | CN¥5.89 Billion | CN¥- | CN¥10.58 Billion | ▼ -1.6 pp |
| 2011 | 57.3% | CN¥5.30 Billion | CN¥5.30 Billion | CN¥- | CN¥9.25 Billion | ▼ -6.5 pp |
| 2010 | 63.8% | CN¥3.14 Billion | CN¥3.14 Billion | CN¥- | CN¥4.93 Billion | ▲ +5.6 pp |
| 2009 | 58.1% | CN¥2.48 Billion | CN¥2.48 Billion | CN¥- | CN¥4.27 Billion | ▼ -3.3 pp |
| 2008 | 61.5% | CN¥1.79 Billion | CN¥1.79 Billion | CN¥- | CN¥2.92 Billion | ▲ +18.7 pp |
| 2007 | 42.8% | CN¥992.14 Million | CN¥992.14 Million | CN¥- | CN¥2.32 Billion | ▼ -18.8 pp |
| 2006 | 61.6% | CN¥711.46 Million | CN¥711.46 Million | CN¥- | CN¥1.16 Billion | ▼ -31.0 pp |
| 2005 | 92.6% | CN¥530.95 Million | CN¥530.95 Million | CN¥- | CN¥573.59 Million | ▲ +12.8 pp |
| 2004 | 79.8% | CN¥408.53 Million | CN¥408.53 Million | CN¥- | CN¥511.88 Million | ▲ +3.0 pp |
| 2003 | 76.8% | CN¥339.83 Million | CN¥339.83 Million | CN¥- | CN¥442.44 Million | ▼ -4.4 pp |
| 2002 | 81.2% | CN¥317.61 Million | CN¥317.61 Million | CN¥- | CN¥391.23 Million | ▲ +31.7 pp |
| 2001 | 49.5% | CN¥180.80 Million | CN¥180.80 Million | CN¥- | CN¥365.10 Million | ▼ -27.9 pp |
| 2000 | 77.4% | CN¥80.51 Million | CN¥80.51 Million | CN¥- | CN¥103.96 Million | — |